C94.3
Mast cell leukemia
Clinical Classification Guidelines
Medical Intelligence & Overview
Mast cell leukemia is a rare and aggressive form of blood cancer characterized by the rapid proliferation of mast cells in the bone marrow and bloodstream. Mast cells are a type of white blood cell involved in allergic responses and immune system regulation. When these cells multiply uncontrollably, it can lead to a variety of symptoms and complications. Due to its rarity and severity, mast cell leukemia requires prompt medical attention and specialized treatment approaches.
Causes & Symptoms
Clinical Causes: Genetic mutations that lead to abnormal growth and proliferation of mast cells Associated with systemic mastocytosis, which may evolve into leukemia Possible environmental or unknown factors contributing to mutation development
Key Symptoms: Persistent fatigue and weakness Fever and night sweats Unintentional weight loss Bone pain or tenderness Gastrointestinal issues such as nausea, vomiting, or diarrhea Skin reactions like flushing, itching, or hives Elevated levels of histamine and other chemical mediators causing allergic symptoms Easy bleeding or bruising due to low platelet counts Enlargement of liver, spleen, or lymph nodes
Diagnostic & Treatment
Diagnosis Path: - Imaging studies like X-rays, CT scans, or MRI to assess organ involvement
Treatment Protocols: - Stem cell transplantation for eligible patients, which may offer a potential cure, though it's associated with significant risks
Clinical Advice & FAQs
Billing Guidance
Is C94.3 a billable ICD-10 code?
Yes, C94.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C94.3?
Clinical documentation must specify the nature of Mast cell leukemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference